PATENT CLAIM ANALYSIS

Application Number: 15899795
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["530", "300000"]

Abstract:
The invention relates to a composition in the form of an injectable aqueous solution, the pH of which is between 6.6 and 7.8, including at least: a) a basal insulin, the isoelectric point pI of which is between 5.8 and 8.5; and b) a hydrophobized anionic polymer. In one embodiment, the compositions according to the invention also include a prandial insulin.

Claim (Index 31):
The composition according to  claim 18 , wherein the concentration of hydrophobized anionic polymer is at most 100 mg/ml.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.47917
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13571026', '15616470', '15616128', '14712696', '15609670']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.704412526204071
- 35 USC 102 Novelty (BERT): 0.5797029576885887
- Combined Prediction Score: 0.6919415693525228
- Mean Citation Score: 366.218702
- Max Citation Score: 525.11975
- Similarity Product: 382.7436745560467

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test